Phibro Animal Health Corporation (PAHC)

Market Cap	1.56B
Revenue (ttm)	1.30B
Net Income (ttm)	48.26M
Shares Out	40.53M
EPS (ttm)	1.19
PE Ratio	32.42
Forward PE	14.66
Dividend	$0.48 (1.24%)
Ex-Dividend Date	Sep 3, 2025

Volume	161,284
Open	39.15
Previous Close	39.01
Day's Range	38.43 - 39.54
52-Week Range	16.16 - 41.57
Beta	0.88
Analysts	Hold
Price Target	27.50 (-28.72%)
Earnings Date	Nov 5, 2025

About PAHC

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• IPO Date: Apr 11, 2014
• Employees: 2,475
• Stock Exchange: NASDAQ
• Ticker Symbol: PAHC
• Website: https://www.pahc.com

Financial Performance

In 2025, Phibro Animal Health's revenue was $1.30 billion, an increase of 27.37% compared to the previous year's $1.02 billion. Earnings were $48.26 million, an increase of 1897.68%.

Analyst Summary

According to 4 analysts, the average rating for PAHC stock is "Hold." The 12-month stock price target is $27.5, which is a decrease of -28.72% from the latest price.

Price Target

$27.5

(-28.72% downside)

Analyst Consensus: Hold